NPS : FDA Changes Tentative Date Of Advisory Committee Review Of Natpara BLA

(RTTNews) - NPS Pharmaceuticals Inc. (NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, said that the U.S. Food and Drug Administration or FDA shifted the tentative date for the Natpara (rhPTH[1-84]) Advisory Committee Meeting to September 12, 2014 from July 24 2014.

A definitive date for the advisory committee meeting is expected to be published by FDA in the Federal Register at least 15 days prior to such meeting.

The Prescription Drug User Fee Act (PDUFA) Action Date of October 24, 2014 remains unchanged.